Dermatology Medical Science Liaison — Field Expert

Galderma; Columbia (SC); Hybrid; USD 140,000 - 190,000; Full time

Benefits offered by this job

Health insurance

401(k) plan with employer match

Generous paid time off

Hybrid work schedules

Job summary

Galderma is hiring a Medical Science Liaison to support the U.S. Nemolizumab team. The MSL will build relationships with physicians, NPs and PAs to provide medical and scientific support, focusing on dermatology indications and emerging data in assigned territories.

The role requires doctor-level credentials and 3+ years of related experience, with travel 70–80% and a strong emphasis on compliant scientific exchange and cross-functional collaboration.

Qualifications

• Doctorate level healthcare degree required (Pharm.D./MD/Ph.D.).
• Strong scientific and clinical understanding in dermatology or immunology.
• Experience with biologics or product launches preferred.
• Solid knowledge of US regulatory requirements and compliant practices.

Responsibilities

• Identify key opinion leaders and build expert networks for Nemolizumab.
• Develop and execute KOL engagement plans and institution plans.
• Communicate medical insights to support medical affairs strategies.
• Lead disease awareness plans and provide educational resources to HCPs.
• Present clinical information and data in a compliant manner to providers.
• Support advisory boards and coordinate with home office teams.

Skills

Excellent communication

Presentation skills

Time management

Team collaboration

Scientific acumen

Business acumen

Regulatory knowledge

Adaptability

Education

Pharm.D., Ph.D., MD required

Doctorate degree

Job description

Galderma is hiring a Medical Science Liaison to support the U.S. Nemolizumab team. The MSL will build relationships with physicians, NPs and PAs to provide medical and scientific support, focusing on dermatology indications and emerging data in assigned territories.

The role requires doctor-level credentials and 3+ years of related experience, with travel 70–80% and a strong emphasis on compliant scientific exchange and cross-functional collaboration.